(CNS) Cohen & Steers - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US19247A1007
CNS: Mutual Funds, Hedge Funds, Real Estate, Infrastructure, Commodities
Cohen & Steers, Inc. (NYSE:CNS) is a leading global investment manager specializing in real assets and alternative income strategies. Founded in 1986 and headquartered in New York, the firm provides investment solutions to institutional and individual investors worldwide. Through its subsidiaries, Cohen & Steers manages a diverse range of portfolios, including equity, fixed income, multi-asset, and commodity strategies. The firm is particularly recognized for its expertise in real estate, infrastructure, natural resources, and preferred securities, offering a unique blend of sector-specific and multi-strategy solutions. Its investment approach combines rigorous fundamental research with a disciplined, risk-aware framework to deliver long-term value for clients.
As of the latest data, Cohen & Steers has a market capitalization of $3.785 billion, with a trailing P/E of 24.27 and a forward P/E of 22.08. The firms price-to-book ratio stands at 7.40, reflecting its strong balance sheet and profitability. With a return on equity (RoE) of 29.56%, Cohen & Steers demonstrates robust operational efficiency. Technically, the stock is trading at $76.20, slightly above its 20-day SMA of $75.57 but below its 50-day and 200-day SMAs of $79.86 and $88.24, respectively. The average true range (ATR) of 3.07 indicates moderate volatility. Over the next three months, based on the current trend, the stock is likely to face resistance near its 50-day SMA and support around its 20-day SMA. Fundamentally, the firms strong profitability and focus on alternative income strategies position it well in the current market environment, though its premium valuation may limit near-term upside.
Additional Sources for CNS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNS Stock Overview
Market Cap in USD | 3,917m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2004-08-13 |
CNS Stock Ratings
Growth Rating | 37.4 |
Fundamental | 34.6 |
Dividend Rating | 53.9 |
Rel. Strength | -6.93 |
Analysts | 3.67/5 |
Fair Price Momentum | 69.85 USD |
Fair Price DCF | 31.90 USD |
CNS Dividends
Dividend Yield 12m | 2.94% |
Yield on Cost 5y | 4.94% |
Annual Growth 5y | 1.69% |
Payout Consistency | 83.9% |
CNS Growth Ratios
Growth Correlation 3m | -88.6% |
Growth Correlation 12m | 34.2% |
Growth Correlation 5y | 45.3% |
CAGR 5y | 9.76% |
CAGR/Max DD 5y | 0.21 |
Sharpe Ratio 12m | 0.16 |
Alpha | 5.06 |
Beta | 0.615 |
Volatility | 40.10% |
Current Volume | 98.2k |
Average Volume 20d | 220.6k |
As of April 30, 2025, the stock is trading at USD 77.13 with a total of 98,194 shares traded.
Over the past week, the price has changed by +3.78%, over one month by -3.89%, over three months by -12.17% and over the past year by +12.86%.
Neither. Based on ValueRay Fundamental Analyses, Cohen & Steers is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 34.59 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNS as of April 2025 is 69.85. This means that CNS is currently overvalued and has a potential downside of -9.44%.
Cohen & Steers has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold CNS.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CNS Cohen & Steers will be worth about 77.4 in April 2026. The stock is currently trading at 77.13. This means that the stock has a potential upside of +0.34%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 81 | 5% |
Analysts Target Price | 97.7 | 26.6% |
ValueRay Target Price | 77.4 | 0.3% |